Abstract
Accumulated evidences implicated that microRNAs may be involved in diabetic neuropathy. Here, we investigated miR-29’s roles in primary isolated dorsal root ganglion (DRG) neurons from STZ-induced diabetic rats. First, miR-29b was found down-regulated after STZ-injection. Inhibitions were increased with time course. Down-regulation of miR-29b was associated with higher apoptosis rate and more serious axonal swelling. Meanwhile, axonogeneration genes were inhibited, whereas neurodegenerative genes were stimulated. Restoration of miR-29b by mimic experiment could reverse the above neuropathy. Furthermore, western blot analysis disclosed that miR-29b could abolish Smad3 activation. In conclusion, the present study identifies that miR-29b could protect DRG from diabetic rats. This protective effects suggested potential therapeutic application of miR-29b in diabetic neuropathy.
Similar content being viewed by others
References
Deshpande, A. D., Harris-Hayes, M., & Schootman, M. (2008). Epidemiology of diabetes and diabetes-related complications. Physical Therapy, 88, 1254–1264.
Boulton, A. J., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., & American Diabetes Association. (2005). Diabetic neuropathies A statement by the American Diabetes Association. Diabetes Care, 28, 956–962.
Said, G., Slama, G., & Selva, J. (1983). Progressive centripetal degeneration of axons in small fibre diabetic neuropathy. Brain, 106, 791–807.
Dolman, C. L. (1963). The morbid anatomy of diabetic neuropathy. Neurology, 13, 135–144.
Watkins, P. J., Gayle, C., Alsanjari, N., et al. (1995). Severe sensory-autonomic neuropathy and endocrinopathy in insulin-dependent diabetes. Quarterly Journal of Medicine, 88, 795–804.
Kishi, M., Tanabe, J., Schmelzer, J. D., & Low, P. A. (2002). Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes, 51, 819–824.
Schmeichel, A. M., Schmelzer, J. D., & Low, P. A. (2003). Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes, 52, 165–171.
Pickup, J. C. (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27, 813–823.
Jeyaseelan, K., Lim, K. Y., & Armugam, A. (2008). MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke, 39, 959–966.
Dharap, A., Bowen, K., Place, R., Li, L. C., & Vemuganti, R. (2009). Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. Journal of Cerebral Blood Flow and Metabolism, 29, 675–687.
Tan, K. S., Armugam, A., Sepramaniam, S., Lim, K. Y., Setyowati, K. D., et al. (2009). Expression profile of microRNAs in young stroke patients. PLoS ONE, 4, e7689.
Yin, K. J., Deng, Z., Huang, H., Hamblin, M., & Xie, C. (2010). miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiology of Diseases, 38, 17–26.
Siegel, C., Li, J., Liu, F., Benashski, S. E., & McCullough, L. D. (2011). miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proceedings of National Academy of Sciences, 108, 11662–11667.
Reinhart, B. J., Weinstein, E. G., Rhoades, M. W., Bartel, B., & Bartel, D. P. (2002). MicroRNAs in plants. Genes & Development, 16, 1616–1626.
Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116, 281–297.
Kloosterman, W. P., & Plasterk, R. H. (2006). The diverse functions of microRNAs in animal development and disease. Developmental Cell, 11, 441–450.
Bushati, N., & Cohen, S. M. (2007). microRNA functions. Annual Review of Cell and Developmental Biology, 23, 175–205.
Rana, T. M. (2007). Illuminating the silence: Understanding the structure and function of small RNAs. Nature Reviews Molecular Cell Biology, 8, 23–36.
Eulalio, A., Huntzinger, E., & Izaurralde, E. (2008). Getting to the root of miRNA mediated gene silencing. Cell, 132, 9–14.
Filipowicz, W., Bhattacharyya, S. N., & Sonenberg, N. (2008). Mechanisms of posttranscriptional regulation by microRNAs: Are the answers in sight? Nature Reviews Genetics, 9, 102–114.
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009). Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nature Cell Biology, 11, 228–234.
Meijer, H. A., Kong, Y. W., Lu, W. T., Wilczynska, A., Spriggs, R. V., et al. (2013). Translational repression and eIF4A2 activity are critical for microRNA mediated gene regulation. Science, 340, 82–85.
Maciotta, S., Meregalli, M., & Torrente, Y. (2013). The involvement of microRNAs in neurodegenerative diseases. Frontiers in Cellular Neuroscience, 7, 265.
Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008). The bifunctional microRNAmiR-9, miR-9∗ regulates REST and CoREST and is down-regulated in Huntington’s disease. Journal of Neuroscience, 28, 14341–14346.
Geekiyanage, H., & Chan, C. (2011). MicroRNA-137, 181c regulates serine palmitoyltransferase and inturnamyloid beta, novel targets in sporadic Alzheimer’s disease. Journal of Neuroscience, 31, 14820–14830.
Huang, T. J., Verkhratsky, A., & Fernyhough, P. (2005). Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Molecular and Cellular Neuroscience, 28, 42–54.
Khanna, S., Rink, C., Ghoorkhanian, R., Gnyawali, S., Heigel, M., Wijesinghe, D. S., et al. (2013). Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. Journal of Cerebral Blood Flow and Metabolism, 33, 1197–1206.
Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proceedings of the National Academy of Sciences of the United States of America, 105, 6415–6420.
Kole, A. J., Swahari, V., Hammond, S. M., & Deshmukh, M. (2011). miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes & Development, 25, 125–130.
Kim, H., Park, J. S., Choi, Y. J., Kim, M. O., Huh, Y. H., Kim, S. W., et al. (2009). Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells, 27, 1686–1696.
Barber, A. J., Lieth, E., Khim, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998). Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. Journal of Clinical Investigation, 102, 783–791.
Russell, J. W., Sullivan, K. A., Windebank, A. J., Herrmann, D. N., & Feldman, E. L. (1999). Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiology of Diseases, 6, 347–363.
Jeon, E. J., Lee, K. Y., Choi, N. S., Lee, M. H., Kim, H. N., Jin, Y. H., et al. (2006). Bone morphogenetic protein-2 stimulates Runx2 acetylation. Journal of Biological Chemistry, 281, 16502–16511.
Maeda, S., Hayashi, M., Komiya, S., Imamura, T., & Miyazono, K. (2004). Endogenous TGF-β signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO Journal, 23, 552–563.
Ikenoue, T., Jingushi, S., Urabe, K., Okazaki, K., & Iwamoto, Y. (1999). Inhibitory effects of activin-a on osteoblast differentiation during cultures of fetal rat calvarial cells. Journal of Cellular Biochemistry, 75, 206–214.
Eijken, M., Swagemakers, S., Koedam, M., Steenbergen, C., Derkx, P., Uitterlinden, A. G., et al. (2007). The activin A-follistatin system: Potent regulator of human extracellular matrix mineralization. FASEB Journal, 21, 2949–2960.
Lynch, M. P., Stein, J. L., Stein, G. S., & Lian, J. B. (1995). The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Experimental Cell Research, 216, 35–45.
Houstis, N., Rosen, E. D., & Lander, E. S. (2006). Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440, 944–948.
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., et al. (2002). A central role for JNK in obesity and insulin resistance. Nature, 420, 333–336.
Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120, 649–661.
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003). c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. Journal of Biological Chemistry, 278, 2896–2902.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, X., Gong, X., Han, S. et al. MiR-29b Protects Dorsal Root Ganglia Neurons from Diabetic Rat. Cell Biochem Biophys 70, 1105–1111 (2014). https://doi.org/10.1007/s12013-014-0029-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0029-y